The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1-(3-Bromo-5-hydroxybenzoyl)piperidin-4-yl)(4-chlorophenyl)-methanone ID: ALA4530498
PubChem CID: 155545776
Max Phase: Preclinical
Molecular Formula: C19H17BrClNO3
Molecular Weight: 422.71
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccc(Cl)cc1)C1CCN(C(=O)c2cc(O)cc(Br)c2)CC1
Standard InChI: InChI=1S/C19H17BrClNO3/c20-15-9-14(10-17(23)11-15)19(25)22-7-5-13(6-8-22)18(24)12-1-3-16(21)4-2-12/h1-4,9-11,13,23H,5-8H2
Standard InChI Key: ZXYNOWGZGQBJTP-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
23.2184 -8.8033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2172 -9.6229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9253 -10.0318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6349 -9.6224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6321 -8.7997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9235 -8.3945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5106 -8.3949 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
25.3433 -10.0299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3446 -10.8471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.0503 -9.6202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7570 -10.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4620 -9.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4649 -8.8095 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.7567 -8.3999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0456 -8.8077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1735 -8.4025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8803 -8.8127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1754 -7.5853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8737 -9.6299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5796 -10.0400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2892 -9.6329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2884 -8.8115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5819 -8.4051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5774 -10.8571 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.9956 -8.4019 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
4 8 1 0
8 9 2 0
8 10 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
13 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
20 24 1 0
22 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 422.71Molecular Weight (Monoisotopic): 421.0080AlogP: 4.54#Rotatable Bonds: 3Polar Surface Area: 57.61Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.16CX Basic pKa: ┄CX LogP: 4.17CX LogD: 4.10Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.74Np Likeness Score: -1.04
References 1. Granchi C, Lapillo M, Glasmacher S, Bononi G, Licari C, Poli G, El Boustani M, Caligiuri I, Rizzolio F, Gertsch J, Macchia M, Minutolo F, Tuccinardi T, Chicca A.. (2019) Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor., 62 (4): [PMID:30715876 ] [10.1021/acs.jmedchem.8b01483 ]